Intuitive Surgical, Inc.
Intuitive Surgical Reports Strong Q4 2025 Financial Results
Summary
Intuitive Surgical, Inc. reported strong financial results for the quarter ended December 31, 2025, with a 19% increase in revenue to $2.87 billion, primarily driven by a 17% growth in da Vinci procedure volume and a 44% increase in Ion procedure volume. The company's GAAP net income attributable to Intuitive was $795 million, or $2.21 per diluted share, while non-GAAP net income was $914 million, or $2.53 per diluted share. Intuitive also provided a 2026 outlook with expected worldwide da Vinci procedure growth of approximately 13% to 15%.
Profitelligence Alerts
Get alerts for ISRG
Be first to know when Intuitive Surgical, Inc. files with the SEC.
Filing Categories
Advertisement
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a pioneering company in the field of robotic-assisted, minimally invasive surgery. It is renowned for its development of the da Vinci Surgical System, which revolutionizes surgical procedures by enhancing precision, flexibility, and control beyond the physical capabilities of the human hand. The company's cornerstone product allows surgeons to perform complex surgeries through small incisions, which can lead to quicker patient recovery, reduced hospital stays, and lower complication rates. Operating predominantly in the healthcare sector, Intuitive Surgical serves a significant role in advancing surgical technology and improving patient outcomes. The company collaborates across diverse medical specialties, including urology, gynecology, and general surgery, to expand the applications and accessibility of its robust surgical systems. As an innovator in the medical device industry, Intuitive Surgical has a profound impact not only on surgical methodologies but also on the economic aspects of medical practices by potentially lowering surgical costs. It continues to shape the future of surgery with its commitment to enhancing robotic-assisted techniques.
Official SEC Documents
Advertisement